Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals.
The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40.
With prostate MRI assessments now being utilized more frequently, experts suggest AI could offer a more sustainable approach to managing growing workloads.
A total of 10 professional associations—also representing pain medicine, anesthesia and rehab specialists—recently messaged more than a dozen payers across the U.S.
The uptick came during a time when the number of ED episodes increased by only 8% at the same institution, with defensive medicine one possible driver.
